SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Potential 10 baggers over the next years

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
From: Stefan Gruenwald1/7/2005 2:35:32 PM
  Read Replies (1) of 3
 
Take a look at IXS.V -- IXSBF.PK

This little company has a platform technology that improves the efficiency of antibodies by 10,000 fold. One single antibody in the clinic can have annual sales of over 1 billion dollars (see Biogen [BIIB] or Genentech [DNA]). They are trading unnoticed on the Vancouver stock exchange under IXS (IXS.V) or on the pink sheets in the US (IXSBF.PK). They have enough financing to get them to the next level. I think, they are an excellent buy right now and might be a big play in future. They presented their technology in December at an antibody conference in San Diego. Some scientists might have bought, that's why you see an increase in volume there. As I mentioned, antibodies are getting really popular now to treat various diseases including many different types of cancer, viral infections, autoimmune diseases, etc. These people here can take antibodies from other companies that have FAILED the clinic (proven low efficiency) and turn them around and make them much more potent. They can then re-enter them into clinical trials (maybe outside the US). There is a lot of potential with there technology and the worst that can happen is that they are getting swallowed by a big pharma company. This could be a small Genentech of Amgen in the makings.

More info can be found on their web site:
innexusbiotech.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext